CD8A and neoplasm: HYAL1 is positively correlated with effector memory CD8+ T cells and Type 17 helper (Th17) cells—both associated with anti-tumor immune responses—suggesting that HYAL1 may contribute to the activation or maintenance of tumor-reactive immunity.